Articles研究業績

2019年

  1. Akamatsu H, Ninomiya K, Kenmotsu H, Morise M, Daga H, Goto Y, et al. The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV. International Journal of Clinical Oncology. 2019; 24(7): 731-70.
  2. Akizawa T, Iwasaki M, Otsuka T, Reusch M, Misumi T. Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial. Advances in Therapy. 2019; 36(6): 1438-54.
  3. Aonuma AO, Nakamura M, Sakamaki K, Murai T, Matsuda C, Itaya K, et al. Incidence of cancer-associated thromboembolism in Japanese gastric and colorectal cancer patients receiving chemotherapy: a single-institutional retrospective cohort analysis (Sapporo CAT study). Bmj Open. 2019; 9(8).
  4. Bando H, Kagawa Y, Kato T, Akagi K, Denda T, Nishina T, et al. A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer. British Journal of Cancer. 2019; 120(10): 982-6.
  5. Fujihara S, Inoue A, Kubota K, Yong KFR, Kondo K. Caregiver Burden and Work Productivity Among Japanese Working Family Caregivers of People with Dementia (vol 26, pg 1252019). International Journal of Behavioral Medicine. 2019; 26(2): 136-42.
  6. Fujihara S, Inoue A, Kubota K, Yong KFR, Kondo K. Caregiver Burden and Work Productivity Among Japanese Working Family Caregivers of People with Dementia. International Journal of Behavioral Medicine. 2019; 26(2): 125-35.
  7. Fujii S, Yoshino T, Yamazaki K, Muro K, Yamaguchi K, Nishina T, et al. Histopathological factors affecting the extraction of high quality genomic DNA from tissue sections for next-generation sequencing. Biomedical Reports. 2019; 11(4): 171-80.
  8. Fujita Y, Taguri M, Yamazaki K, Tsurutani J, Sakai K, Tsushima T, et al. aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer. Oncologist. 2019; 24(3): 327-37.
  9. Fukuma S, Ikenoue T, Sasaki S, Saigusa Y, Misumi T, Saito Y, Yamada Y, Goto R, Taguri M. Nudging patients with chronic kidney disease at screening to visit physicians: A protocol of a pragmatic randomized controlled trial. Contemp Clin Trials Commun. 2019; 16: 100429.
  10. Hara K, Takeda A, Tsurugai Y, Saigusa Y, Sanuki N, Eriguchi T, Maeda S, Tanaka K, Numata K. Radiotherapy for hepatocellular carcinoma results in comparable survival to radiofrequency ablation: A propensity score analysis. Hepatology. 2019; 69(6): 2533-2545.
  11. Hasegawa T, Furugori M, Kubota K, Asai-Sato M, Yashiro-Kawano A, Kato H, et al. Does the extension of the type of hysterectomy contribute to the local control of endometrial cancer? International Journal of Clinical Oncology. 2019; 24(9): 1129-36.
  12. Hata T, Ikeda M, Miyata H, Nomura M, Gotoh M, Sakon M, et al. Frequency and risk factors for venous thromboembolism after gastroenterological surgery based on the Japanese National Clinical Database (516 217 cases). Annals of Gastroenterological Surgery. 2019; 3(5): 534-43.
  13. Hattori S, Kishida I, Suda A, Kawanishi C, Miyauchi M, Shiraishi Y, Fujibayashi M, Tsujita N, Ishii C, Moritani T, Saigusa Y, Hirayasu Y. A return to work program improves parasympathetic activity and psychiatric symptoms in workers on sick leave due to depression. Heliyon. 2019; 5(7): e02151.
  14. Higashihara E, Yamamoto K, Kaname S, Okegawa T, Tanbo M, Yamaguchi T, et al. Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases. Clinical and Experimental Nephrology. 2019; 23(1): 100-11.
  15. Inoue T, Iijima H, Yamada T, Okuyama Y, Takahashi K, Nishida T, et al. A prospective multicenter observational study evaluating the risk of periendoscopic events in patients using anticoagulants: the Osaka GIANT Study. Endoscopy International Open. 2019; 7(2): E104-E14.
  16. Kageyama K, Yamamoto A, Jogo A, Nota T, Murai K, Ogawa S, et al. Usefulness of Venous Pressure Measurement in Endovascular Treatment of Budd-Chiari Syndrome: A Retrospective Cohort Study. Internal Medicine. 2019; 58(20): 2923-9.
  17. Kinguchi S, Wakui H, Ito Y, Kondo Y, Azushima K, Osada U, et al. Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study). Cardiovascular Diabetology. 2019; 18(1).
  18. Kino T, Yamamoto Y, Saigusa Y, Aoki S, Miyagi E. Adverse pregnancy outcomes related to preterm cesarean delivery. Eur J Obstet Gynecol Reprod Biol. 2019; 234: 89-91.
  19. Kinoshita H, Nishioka H, Ikeda A, Ikoma K, Sameshima Y, Ohi H, Tatsuno M, Kouyama J, Kawamoto C, Mitsui T, Tamura Y, Hashimoto Y, Nishio M, Ogashiwa T, Saigusa Y, Maeda S, Kimura H, Kunisaki R, Koike K. Remission induction, maintenance, and endoscopic outcome with oral 5-aminosalicylic acid in intestinal Behçet's disease. J Gastroenterol Hepatol. 2019; 34(11): 1929-1939.
  20. Kojima T, Takami M, Shindo R, Saigusa Y, Miyagi E, Aoki S. Perinatal outcomes of recurrent placental abruption. J Matern Fetal Neonatal Med. 2019; 10: 1-5.
  21. Komeya M, Odaka H, Asano J, Asai T, Saigusa Y, Ogawa T, Yao M, Matsuzaki J. Development and internal validation of a nomogram to predict perioperative complications after flexible ureteroscopy for renal stones in overnight ureteral catheterization cases. World J Urol. 2019; 29.
  22. Komuro H, Shigemura J, Uchino S, Takahashi S, Nagamine M, Tanichi M, et al. Longitudinal Factors Associated With Increased Alcohol and Tobacco Use in Fukushima Nuclear Power Plant Workers 32 Months After the Nuclear Disaster The Fukushima News Project Study. Journal of Occupational and Environmental Medicine. 2019; 61(1): 69-74.
  23. Kubo H, Hiroshima Y, Mori R, Saigusa Y, Murakami T, Yabushita Y, Sawada Y, Homma Y, Kumamoto T, Matsuyama R, Endo I. MiR-194-5p in pancreatic ductal adenocarcinoma peritoneal washings is associated with peritoneal recurrence and overall survival in peritoneal cytology-negative patients. Ann Surg Oncol. 2019; 26(13): 4506-4514.
  24. Kurajoh M, Fukumoto S, Murase T, Nakamura T, Ishihara T, Go H, et al. Insulin Resistance Associated with Plasma Xanthine Oxidoreductase Activity Independent of Visceral Adiposity and Adiponectin Level: MedCity21 Health Examination Registry. International Journal of Endocrinology. 2019;2019.
  25. Kurajoh M, Yamasaki A, Nagasaki T, Nagata Y, Yamada S, Imanishi Y, et al. Thyroid blood flow in inferior thyroid artery as predictor for increase in levothyroxine dosage during pregnancy in women with Hashimoto's thyroiditis - a retrospective study. Bmc Pregnancy and Childbirth. 2019;19.
  26. Miyamoto H, Kunisaki C, Sato S, Tanaka Y, Sato K, Kosaka T, Yukawa N, Akiyama H, Saigusa Y, Endo I. Tumor volume index as a prognostic factor in patients after curative esophageal cancer resection. Ann Surg Oncol. 2019; 26(6): 1909-1915.
  27. Morizane C, Okuyama H, Ikeda M, Furuse J, Furukawa M, Ueno M, et al. A Phase II Study of Everolimus in Patients with Unresectable Pancreatic Neuroendocrine Carcinoma Refractory or Intolerant to Platinum-Contained Chemotherapy. Neuroendocrinology. 2019; 108: 175-.
  28. Muro K, Itabashi M, Hashida H, Masuishi T, Bando H, Denda T, et al. Observational study of first-line chemotherapy including cetuximab in patients with metastatic colorectal cancer: CORAL trial. Japanese Journal of Clinical Oncology. 2019; 49(4): 339-46.
  29. Murohashi K, Hara Y, Saigusa Y, Kobayashi N, Sato T, Yamamoto M, Kudo M, Kaneko T. Clinical significance of Charlson comorbidity index as a prognostic parameter for patients with acute or subacute idiopathic interstitial pneumonias and acute exacerbation of collagen vascular diseases-related interstitial pneumonia. J Thorac Dis. 2019; 11(6): 2448-2457.
  30. Muto Y, Kitano S, Tsutsumida A, Namikawa K, Takahashi A, Nakamura Y, et al. Investigation of clinical factors associated with longer overall survival in advanced melanoma patients treated with sequential ipilimumab. Journal of Dermatology. 2019; 46(6): 498-506.
  31. Nakamura Y, Yamanaka T, Chin K, Cho H, Katai H, Terashima M, et al. Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy. Annals of Surgical Oncology. 2019; 26(2): 465-72.
  32. Narita A, Takeda A, Eriguchi T, Saigusa Y, Sanuki N, Tsurugai Y, Enomoto T, Stereotactic body radiotherapy for primary non-small cell lung cancer patients with clinical T3-4N0M0 (UICC 8th edition): outcomes and patterns of failure. J Radiat Res. 2019; 60(5): 639-649.
  33. Numata M, Sawazaki S, Aoyama T, Tamagawa H, Godai T, Sato T, Saeki H, Saigusa Y, Taguri M, Mushiake H, Oshima T, Yukawa N, Shiozawa M, Masuda M, Rino Y. Laparoscopic surgery in patients diagnosed with clinical N2 colon cancer. Surg Today. 2019; 49(6): 507-512.
  34. Numata M, Sawazaki S, Aoyama T, Tamagawa H, Sato T, Saeki H, Saigusa Y, Taguri M, Mushiake H, Oshima T, Yukawa N, Shiozawa M, Rino Y, Masuda M. D3 lymph node dissection reduces recurrence after primary resection for elderly patients with colon cancer. Int J Colorectal Dis. 2019; 34(4): 621-628.
  35. Ogino I, Watanabe S, Misumi T, Hata M, Kunisaki C. Lymph Node Metastases Diagnosed by F-18-FDG-PET/CT in Esophageal Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy. Anticancer Research. 2019; 39(9): 4977-85.
  36. Oki E, Emi Y, Yamanaka T, Uetake H, Muro K, Takahashi T, et al. Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial). British Journal of Cancer. 2019; 121(3): 222-9.
  37. Sato S, Kunisaki C, Tanaka Y, Sato K, Miyamoto H, Yukawa N, et al. Curative-Intent Surgery for Stage IV Advanced Gastric Cancer: Who Can Undergo Surgery and What Are the Prognostic Factors for Long-Term Survival? Annals of Surgical Oncology. 2019; 26(13): 4452-63.
  38. Shimpuku Y, Madeni FE, Horiuchi S, Kubota K, Leshabari SC. A family-oriented antenatal education program to improve birth preparedness and maternal-infant birth outcomes: A cross sectional evaluation study. Reproductive Health. 2019; 16.
  39. Shindo R, Aoki M, Yamamoto Y, Misumi T, Miyagi E, Aoki S. Optimal gestational weight gain for underweight pregnant women in Japan. Scientific Reports. 2019; 9: 18129.
  40. Shitara K, Yamanaka T, Denda T, Tsuji Y, Shinozaki K, Komatsu Y, et al. REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients. Annals of Oncology. 2019; 30(2): 259-65.
  41. Suwa Y, Watanabe J, Ota M, Suzuki S, Suwa H, Watanabe K, et al. Randomized phase II trial of the prophylactic use of celecoxib for the prevention of oxaliplatin-related peripheral vascular pain in Capeox (YCOG1205). Cancer Chemotherapy and Pharmacology. 2019; 83(3): 419-24.
  42. Suzuki Y, Sukegawa A, Nishikawa A, Kubota K, Motoki Y, Asai-Sato M, et al. Current knowledge of and attitudes toward human papillomavirus-related disease prevention among Japanese: A large-scale questionnaire study. Journal of Obstetrics and Gynaecology Research. 2019; 45(5): 994-1005.
  43. Tachino J, Yamamoto K, Shimizu K, Shintani A, Kimura A, Ogura H, et al. Quick risk assessment profile (qRAP) is a prediction model for post-traumatic venous thromboembolism. Injury-International Journal of the Care of the Injured. 2019; 50(9): 1540-4.
  44. Taguchi Y, Matsushita K, Ishikawa T, Matsumoto K, Hosoda J, Iguchi K, et al. Successful screening of sleep-disordered breathing using a pacemaker-based algorithm in Japan. Journal of Cardiology. 2019; 73(5): 394-400.
  45. Takahashi K, Yamamoto K. An exact test for comparing two predictive values in small-size clinical trials. Pharmaceutical Statistics. 2020; 19(1): 31-43.
  46. Tochio A, Obata S, Saigusa Y, Shindo R, Miyagi E, Aoki S. Dose pre-eclampsia without proteinuria lead to different pregnancy outcomes than pre-eclampsia with proteinuria? J Obstet Gynaecol Res. 2019; 45(8): 1576-1583.
  47. Tokinaga-Uchiyama A, Mizushima T, Akimoto K, Nagashima Y, Sasaki K, Nakaya M, et al. Aberrant Nuclear Localization of aPKC lambda/iota is Associated With Poorer Prognosis in Uterine Cervical Cancer. International Journal of Gynecological Pathology. 2019; 38(4): 301-9.
  48. Tomita N, Kunieda K, Maeda A, Hamada C, Yamanaka T, Sato T, et al. Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study. British Journal of Cancer. 2019; 120(7): 689-96.
  49. Tsuji D, Suzuki K, Kawasaki Y, Goto K, Matsui R, Seki N, et al. Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial. Supportive Care in Cancer. 2019; 27(3): 1139-47.
  50. Urakawa R, Tarutani M, Kubota K, Uejima E. Hand Foot Syndrome Has the Strongest Impact on QOL in Skin Toxicities of Chemotherapy. Journal of Cancer. 2019; 10(20): 4846-51.
  51. Wada-Shimosato Y, Tanoshima R, Hiratoko K, Takeuchi M, Tsujimoto SI, Shiba N, et al. Effectiveness of acyclovir prophylaxis against varicella zoster virus disease after allogeneic hematopoietic cell transplantation: A systematic review and meta-analysis. Transplant Infectious Disease. 2019; 21(3).
  52. Yamamoto N, Hamaguchi S, Akeda Y, Santanirand P, Chaihongsa N, Sirichot S, et al. Rapid screening and early precautions for carbapenem-resistant Acinetobacter baumannii carriers decreased nosocomial transmission in hospital settings: a quasi-experimental study. Antimicrobial Resistance and Infection Control. 2019; 8.
  53. Yokose M, Mihara T, Takaya M, Yamamoto T, Saigusa Y, Takaki S, Goto T. The perfusion index measured by the pulse oximeter affects the agreement between ClearSight and the arterial catheter-based blood pressures: A prospective observational study. PLoS One. 2019; 14(7): e0219511.
  54. Yoshino T, Yamanaka T, Oki E, Kotaka M, Manaka D, Eto T, et al. Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer The ACHIEVE Phase 3 Randomized Clinical Trial. Jama Oncology. 2019; 5(11): 1574-81.
  55. Zenda S, Ota Y, Kiyota N, Okano S, Fujii M, Kitamura M, et al. A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinoma of the Head and Neck (CSPOR HN01: ECRIPS Study). Frontiers in Oncology. 2019; 9.

2018年

  1. Ito Y, Tsuda T, Minatogawa H, Kano S, Sakamaki K, Ando M, Tsugawa K, Kojima Y,Furuya N, Matsuzaki K, Fukuda M, Sugae S, Ohta I, Arioka H, Tokuda Y, Narui K, Tsuboya A, Suda T, Morita S, Boku N, Yamanaka T, Nakajima TE. Placebo-Controlled, Double-Blinded Phase III Study Comparing Dexamethasone on Day 1 With Dexamethasone on Days 1 to 3 With Combined Neurokinin-1 Receptor Antagonist and Palonosetron in High-Emetogenic Chemotherapy. J Clin Oncol. 2018 Apr; 36(10): 1000-1006.
  2. Akamatsu H, Teraoka S, Koh Y, Yamanaka T, Yamamoto N, Nakagawa K. A Phase II Study of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer who Responded to Prior PD-1/L1 Inhibitors: West Japan Oncology Group 9616L (WJOG9616L). Clin Lung Cancer. 2018 Dec 11. pii: S1525-7304(18)3032
  3. Shimizu H, Suzuki K, Uchikura T, Tsuji D, Yamanaka T, Hashimoto H, Goto K, Matsui R, Seki N, Shimada T, Ikeda S, Ikegami N, Hama T, Yamamoto N, Sasaki T. Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial). J Pharm Health Care Sci. 2018 Dec 10;4:31.
  4. Sato S, Kunisaki C, Tanaka Y, Sato K, Miyamoto H, Yukawa N, Fujii Y, Kimura J, Takagawa R, Takahashi M, Kosaka T, Akiyama H, Saigusa Y, Taguri M, Yamanaka T, Endo I. A Phase II Study of Tri-weekly Low-dose Nab-paclitaxel Chemotherapy for Patients with Advanced Gastric Cancer. Anticancer Res. 2018 Dec;38(12):6911-6917.
  5. Sasaki T, Seto T, Yamanaka T, Kunitake N, Shimizu J, Kodaira T, Nishio M, Kozuka T, Takahashi T, Harada H, Yoshimura N, Tsutsumi S, Kitajima H, Kataoka M, Ichinose Y, akagawa K, Nishimura Y, Yamamoto N, Nakanishi Y. A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L. Br J Cancer. 2018 Sep; 119(6): 675-682.
  6. Nakamura Y, Yamanaka T, Chin K, Cho H, Katai H, Terashima M, Misawa K, Hirao M,Yoshida K, Oki E, Sasako M, Emi Y, Bando H, Kawashima Y, Fukunaga T, Gotoh M, Ishibashi T, Shitara K. Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy. Ann Surg Oncol. 2019 Feb; 26(2): 465-472.
  7. Taniguchi H, Okamoto W, Muro K, Akagi K, Hara H, Nishina T, Kajiwara T, Denda T, Hironaka S, Kudo T, Satoh T, Yamanaka T, Abe Y, Fukushima Y, Yoshino T. Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study. Neoplasia. 2018 Dec;20(12):1219-1226.
  8. Oki E, Kato T, Bando H, Yoshino T, Muro K, Taniguchi H, Kagawa Y, Yamazaki K, Yamaguchi T, Tsuji A, Iwamoto S, Nakayama G, Emi Y, Touyama T, Nakamura M, Kotaka M, Sakisaka H, Yamanaka T, Kanazawa A. A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study. Clin Colorectal Cancer. 2018 Jun;17(2): 147-155.
  9. Ikeda S, Kato T, Ogura T, Sekine A, Oda T, Masuda N, Igawa S, Katono K, Otani S, Yamada K, Saito H, Kondo T, Hosomi Y, Nakahara Y, Nishikawa M, Utumi K, Misumi Y, Yamanaka T, Sakamaki K, Okamoto H. Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016. BMC Cancer. 2018 Mar; 18(1): 241.
  10. Kondoh CN, Miura Y, Yamanaka T. Sunitinib Alone or after Nephrectomy in Renal Cancer. N Engl J Med. 2018 Nov; 379(19): 1877.
  11. Wu YL, Yang JC, Kim DW, Lu S, Zhou J, Seto T, Yang JJ, Yamamoto N, Ahn MJ, Takahashi T, Yamanaka T, Kemner A, Roychowdhury D, Paolini J, Usari T, Wilner KD, Goto K. Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer. Clin Oncol. 2018 May ; 36(14): 1405-1411.
  12. Grothey A, Sobrero AF, Shields AF, Yoshino T, Paul J, Taieb J, Souglakos J, Shi Q, Kerr R, Labianca R, Meyerhardt JA, Vernerey D, Yamanaka T, Boukovinas I, Meyers JP, Renfro LA, Niedzwiecki D, Watanabe T, Torri V, Saunders M, Sargent DJ, Andre T, Iveson T. Duration of Adjuvant Chemotherapy for Stage III Colon Cancer. N Engl J Med. 2018 Mar; 378(13): 1177-1188.
  13. Kessoku T, Imajo K, Kobayashi T, Honda Y, Kato T, Ogawa Y, Tomeno W, Kato S,Higurashi T, Yoneda M, Kirikoshi H, Kubota K, Taguri M, Yamanaka T, Usuda H, Wada K, Saito S, Nakajima A. Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design. Contemp Clin Trials. 2018 Jun; 69: 40-47.
  14. Kunisaki C, Miyamoto H, Sato S, Tanaka Y, Sato K, Izumisawa Y, Yukawa N, Kosaka T, Akiyama H, Saigusa Y, Sakamaki K, Yamanaka T, Endo I. Surgical Outcomes of Reduced-Port Laparoscopic Gastrectomy Versus Conventional Laparoscopic Gastrectomy for Gastric Cancer: A Propensity-Matched Retrospective Cohort Study. Ann Surg Oncol. 2018 Nov; 25(12): 3604-3612.
  15. Bando H, Okamoto W, Fukui T, Yamanaka T, Akagi K, Yoshino T. Utility of thequasi-monomorphic variation range in unresectable metastatic colorectal cancer patients. Cancer Sci. 2018 Nov;109(11):3411-3415.
  16. Tsuji D, Suzuki K, Kawasaki Y, Goto K, Matsui R, Seki N, Hashimoto H, Hama T, Yamanaka T, Yamamoto N, Itoh K. Risk factors associated with chemotherapy-inducednausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial. Support Care Cancer. 2019 Mar;27(3):1139-1147.
  17. Hibi K, Kozuma K, Sonoda S, Endo T, Tanaka H, Kyono H, Koshida R, Ishihara T, Awata M, Kume T, Tanabe K, Morino Y, Tsukahara K, Ikari Y, Fujii K, Yamasaki M, Yamanaka T, Kimura K, Isshiki T; VAMPIRE 3 Investigators. A Randomized Study of Distal Filter Protection Versus Conventional Treatment During Percutaneous Coronary Intervention in Patients With Attenuated Plaque Identified by Intravascular Ultrasound. JACC Cardiovasc Interv. 2018 Aug 27;11(16):1545-1555.
  18. Ogawa Y, Imajo K, Honda Y, Kessoku T, Tomeno W, Kato S, Fujita K, Yoneda M, Saito S, Saigusa Y, Hyogo H, Sumida Y, Itoh Y, Eguchi K, Yamanaka T, Wada K, Nakajima A. Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin. Sci Rep. 2018 Jul 27;8(1):11365.
  19. Kumagai H, Kusaba H, Yamanaka T, Nio K, Inadomi K, Takayoshi K, Ito M, Tamura S, Makiyama A, Makiyama C, Hirano G, Shibata Y, Shirakawa T, Mitsugi K, Ariyama H, Esaki T, Akashi K, Baba E. A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapy. Medicine (Baltimore). 2018 Jun;97(25):e11042.
  20. Tanaka F, Yokomise H, Soejima T, Uramoto H, Yamanaka T, Nakagawa K, Yamamoto N, Nishimura Y, Niwa H, Okada M, Nakagawa T, Yamashita M. Induction Chemoradiotherapy (50 Gy), Followed by Resection, for Stage IIIA-N2 Non-Small Cell Lung Cancer. Ann Thorac Surg. 2018 Oct;106(4):1018-1024.
  21. Sawada K, Nakamura Y, Yamanaka T, Kuboki Y, Yamaguchi D, Yuki S, Yoshino T, Komatsu Y, Sakamoto N, Okamoto W, Fujii S. Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2018 Sep;17(3):198-205.
  22. Kogure Y, Saka H, Takiguchi Y, Atagi S, Kurata T, Ebi N, Inoue A, Kubota K, Takenoyama M, Seto T, Kada A, Yamanaka T, Ando M, Yamamoto N, Gemma A, Ichinose Y. A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol. Clin Lung Cancer. 2018 Sep;19(5):e711-e715.
  23. Kotaka M, Yamanaka T, Yoshino T, Manaka D, Eto T, Hasegawa J, Takagane A, Nakamura M, Kato T, Munemoto Y, Nakamura F, Bando H, Taniguchi H, Gamoh M, Shiozawa M, Saji S, Maehara Y, Mizushima T, Ohtsu A, Mori M. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer. ESMO Open. 2018 Apr ;3(3):e000354.
  24. Takano T, Tsurutani J, Takahashi M, Yamanaka T, Sakai K, Ito Y, Fukuoka J, Kimura H, Kawabata H, Tamura K, Matsumoto K, Aogi K, Sato K, Nishio K, Nakagawa K, Saeki T. A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOP. Breast. 2018 Aug;40:67-75.
  25. Naito Y, Takahashi H, Shitara K, Okamoto W, Bando H, Kuwata T, Kuboki Y, Matsumoto S, Miki I, Yamanaka T, Watanabe A, Kojima M. Feasibility study of cancer genome alterations identified by next generation sequencing: ABC study. Jpn J Clin Oncol. 2018 Jun 1;48(6):559-564.
  26. Ogawa Y, Honda Y, Kessoku T, Tomeno W, Imajo K, Yoneda M, Kawanaka M, Kirikoshi H, Ono M, Taguri M, Saito S, Yamanaka T, Wada K, Nakajima A. Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S:useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2018 Oct;33(10):1795-1803.
  27. Ueno T, Saji S, Masuda N, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Iwata H, Yamanaka T, Sasano H, Toi M. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: afollow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial. ESMO Open. 2018 Feb 14;3(2):e000314.
  28. Tsuchiya N, Kunisaki C, Makino H, Kimura J, Takagawa R, Sato S, Tanaka Y, Sato K, Miyamoto H, Kosaka T, Akiyama H, Endo I, Sakamaki K, Yamanaka T. Feasibility of Laparoscopy-assisted Gastrectomy for Gastric Cancer in Elderly Patients: A Case-Control Study. Surg Laparosc Endosc Percutan Tech. 2018 Apr;28(2):102-107.
  29. Noguchi G, Nakaigawa N, Taguri M, Tsutsumi S, Saito Y, Fukui S, Yasui M, Tokita T, Mitome T, Tatenuma T, Kuroda S, Abe K, Ueno D, Namura K, Umemoto S, Takizawa A, Ohta J, Ueki T, Watanabe T, Kobayashi K, Kondo K, Kishida T, Kanno H, Kitami K, Yamanaka T, Yao M. Time-dependent change in relapse sites of renal cell carcinoma after curative surgery. Clin Exp Metastasis. 2018 Feb;35(1-2):69-75.
  30. Tahara M, Kiyota N, Yokota T, Hasegawa Y, Muro K, Takahashi S, Onoe T, Homma A, Taguchi J, Suzuki M, Minato K, Yane K, Ueda S, Hara H, Saijo K, Yamanaka T. Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02). Ann Oncol. 2018 Apr 1;29(4):1004-1009.
  31. Nagano H, Obi S, Hatano E, Kaneko S, Kanai F, Omata M, Tsuji A, Itamoto T, Yamamoto K, Tanaka M, Kubo S, Hirata K, Nakamura H, Tomimaru Y, Yamanaka T, Kojima S, Monden M. Multicenter, randomized, controlled trial of S-1 monotherapy versus S-1 and interferon-α combination therapy for hepatocellular carcinoma with extrahepatic metastases. Hepatol Res. 2018 Aug;48(9):717-726.
  32. Kuno H, Sakamaki K, Fujii S, Sekiya K, Otani K, Hayashi R, Yamanaka T, Sakai O, Kusumoto M. Comparison of MR Imaging and Dual-Energy CT for the Evaluation of Cartilage Invasion by Laryngeal and Hypopharyngeal Squamous Cell Carcinoma. AJNR Am J Neuroradiol. 2018 Jan 25. [inpress]
  33. Kiyokuni M, Kawashima C, Konishi M, Sakamaki K, Iwata K, Nakayama N, Komura N,Kosuge M, Sugano T, Ishigami T, Endo T, Ishikawa T, Yamanaka T, Kimura K, Tamura K. Relationship between sleep-disordered breathing and renal dysfunction in acute coronary syndrome. J Cardiol. 2018 Feb;71(2):168-173.
  34. Takahashi K, Yamamoto K. The performance of randomization methods in consideration of prognostic factors for small-size clinical trials: a simulation study. Journal of the Japanese Society of Computational Statistics. 2018; 30(2): 65–74.
  35. Nagami Y, Ominami M, Shiba M, Sakai T, Fukunaga S, Sugimori S, Otani K, Hosomi S, Tanaka F, Taira K, Kamata N, Yamagami H, Tanigawa T, Watanabe T, Ishihara T, Yamamoto K, Fujiwara Y. Prediction of esophageal tricture in patients given locoregional triamcinolone injections immediately after endoscopic submucosal dissection. Dig Endosc. 2018 Mar; 30(2): 198-205. 
  36. Ebina K, Hashimoto M, Yamamoto W, Ohnishi A, Kabata D, Hirano T, Hara R, Katayama M, Yoshida S, Nagai K, Son Y, Amuro H, Akashi K, Fujimura T, Hirao M, Yamamoto K, Shintani A, Kumanogoh A, Yoshikawa H. Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study. PLoS One. 2018 Mar; 13(3): e0194130.
  37. Minamino T, Higo S, Araki R, Hikoso S, Nakatani D, Suzuki H, Yamada T, Okutsu M, Yamamoto K, Fujio Y, Ishida Y, Ozawa T, Kato K, Toba K, Aizawa Y, Komuro I: EPO-AMI-II Investigators. Low-Dose Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction (EPO-AMI-II) - A Randomized Controlled Clinical Trial. Circ J. 2018 Mar; 82(4): 1083-1091. 
  38. Xu P, Kai C, Kawasaki S, Kobayashi Y, Yamamoto K, Tsujikawa M, Hayashi R, Nishida K. A New in Vitro Model of GDLD by Knocking Out TACSTD2 and Its Paralogous Gene EpCAM in Human Corneal Epithelial Cells. Transl Vis Sci Technol. 2018 Dec; 7(6): 30. 
  39. Tamori S, Nozaki Y, Motomura H, Nakane H, Katayama R, Onaga C, Kikuchi E, Shimada N, Suzuki Y, Noike M, Hara Y, Sato K, Sato T, Yamamoto K, Hanawa T, Imai M, Abe R, Yoshimori A, Takasawa R, Tanuma SI, Akimoto K. Glyoxalase 1 gene is highly expressed in basal-like human breast cancers and contributes to survival of ALDH1-positive breast cancer stem cells. Oncotarget. 2018 Nov; 9(92): 36515-36529.
  40. Takahashi H, Watanabe Y, Tanaka H, Mihara M, Mochizuki H, Takahashi K, Yamamoto K, Liu T, Wang Y, Tomiyama N. Comprehensive MRI quantification of the substantia nigra pars compacta in Parkinson's disease. Eur J Radiol. 2018 Dec; 109: 48-56. 
  41. Higashihara E, Yamamoto K, Kaname S, Okegawa T, Tanbo M, Yamaguchi T, Shigemori K, Miyazaki I, Yokoyama K, Nutahara K. Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases. Clin Exp Nephrol. 2019 Jan; 23(1): 100-111.
  42. Inoue T, Iijima H, Yamada T, Okuyama Y, Takahashi K, Nishida T, Ishihara R, Akasaka T, Kobayashi I, Kuroshima T, Yasunaga Y, Yamamoto K, Nakahara M, Doi Y, Nakajima S, Mukai A, Masuda E, Yoshii S, Hayashi Y, Minamiguchi H, Sakata Y, Yamamoto K, Tsujii M, Takehara T. A prospective multicenter observational study evaluating the risk of periendoscopic events in patients using anticoagulants:the Osaka GIANT Study. Endosc Int Open. 2019 Feb; 7(2): E104-E114.
  43. Shimazu A, Schaufeli WB, Kubota K, Watanabe K, Kawakami N. Is too much work engagement detrimental? Linear or curvilinear effects on mental health and job performance. PLoS One. 2018 Dec; 13(12): e0208684. 
  44. Komuro H, Shigemura J, Uchino S, Takahashi S, Nagamine M, Tanichi M, Saito T, Toda H, Kurosawa M, Kubota K, Misumi T, Takahashi S, Nomura S, Shimizu K, Yoshino A, Tanigawa T; Fukushima NEWS Project Collaborators. Longitudinal Factors Associated With Increased Alcohol and Tobacco Use in Fukushima Nuclear Power Plant Workers 32 Months After the Nuclear Disaster: The Fukushima News Project Study. J Occup Environ Med. 2019 Jan; 61(1): 69-74.
  45. Shimpuku Y, Madeni FE, Horiuchi S, Kubota K, Leshabari SC. Evaluation of a family-oriented antenatal group educational program in rural Tanzania: a pre-test/post-test study. Reprod Health. 2018 Jun; 15(1): 117.
  46. Matsui N, Imajo K, Yoneda M, Kessoku T, Honda Y, Ogawa Y, Tomeno W, Fujisawa N, Misumi T, Kazumi K, Saito S, Nakajima A. Magnetic resonance elastography increases usefulness and safety of non-invasive screening for esophageal varices. J Gastroenterol Hepatol. 2018 Dec; 33(12): 2022-2028.
  47. Tokinaga-Uchiyama A, Mizushima T, Akimoto K, Nagashima Y, Sasaki K, Nakaya MA, Ohashi K, Kubota K, Maruyama Y, Kato H, Hirahara F, Miyagi E, Ohno S, Asai-Sato M. Aberrant Nuclear Localization of aPKCλ/ι is Associated With Poorer Prognosis in Uterine Cervical Cancer. Int J Gynecol Pathol. 2018. (in press)
  48. Fujihara S, Inoue A, Kubota K, Yong KFR, Kondo K. Caregiver Burden and Work Productivity Among Japanese Working Family Caregivers of People with Dementia. Int J Behav Med. 2018. (in press)
  49. Hagiwara Y, Kasai J, Nakanishi S, Saigusa Y, Miyagi E, Aoki S. Should the IADPSG criteria be applied when diagnosing early-onset gestational diabetes? Diabetes Res Clin Pract. 2018.(in press)
  50. Hattori S, Suda A, Kishida I, Miyauchi M, Shiraishi Y, Fujibayashi M, Tsujita N, Ishii C, Ishii N, Moritani T, Saigusa Y, Hirayasu Y. Association between dysfunction of autonomic nervous system activity and mortality in schizophrenia. Compr Psychiatry. 2018 Oct; 86: 119-122.
  51. Nishio M, Ishii Y, Hashimoto Y, Otake H, Ogashiwa T, Tsuda S, Yasuhara H, Saigusa Y, Kimura H, Maeda S, Kunisaki R. Short- and long-term efficacy of adalimumab salvage therapy after failure of calcineurin inhibitors in steroid-refractory ulcerative colitis. Scand J Gastroenterol. 2018.(in press)

2017年

  1. Ishiguro H, Saji S, Nomura S, Tanaka S, Ueno T, Onoue M, Iwata H, Yamanaka T, Sasaki Y, Toi M. A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S-1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG-M01 study). Cancer Med. 2017 Dec;6(12):2909-2917.
  2. Horita N, Nagashima A, Nakashima K, Shibata Y, Ito K, Goto A, Yamanaka T, Kaneko T. The best platinum regimens for chemo-naive incurable non-small cell lung cancer: network meta-analysis. Sci Rep. 2017 Oct 13;7(1):13185.
  3. Maehara Y, Shirabe K, Kohnoe S, Emi Y, Oki E, Kakeji Y, Baba H, Ikeda M, Kobayashi M, Takayama T, Natsugoe S, Haraguchi M, Yoshida K, Terashima M, Sasako M, Yamaue H, Kokudo N, Uesaka K, Uemoto S, Kosuge T, Sawa Y, Shimada M, Doki Y, Yamamoto M, Taketomi A, Takeuchi M, Akazawa K, Yamanaka T, Shimokawa M. Erratum to: Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial. Surg Today. 2017 Dec;47(12):1539-1540.
  4. Sugano N, Aoyama T, Sato T, Kamiya M, Amano S, Yamamoto N, Nagashima T, Ishikawa Y, Masudo K, Taguri M, Yamanaka T, Yamamoto Y, Matsukawa H, Shiraisi R, Oshima T, Yukawa N, Rino Y, Masuda M. Randomized phase II study of TJ-54 (Yokukansan) for postoperative delirium in gastrointestinal and lung malignancy patients. Mol Clin Oncol. 2017 Oct;7(4):569-573.
  5. Honda Y, Kessoku T, Sumida Y, Kobayashi T, Kato T, Ogawa Y, Tomeno W, Imajo K, Fujita K, Yoneda M, Kataoka K, Taguri M, Yamanaka T, Seko Y, Tanaka S, Saito S, Ono M, Oeda S, Eguchi Y, Aoi W, Sato K, Itoh Y, Nakajima A. Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. BMC Gastroenterol. 2017 Aug 8;17(1):96.
  6. Yoshioka H, Katakami N, Okamoto H, Iwamoto Y, Seto T, Takahashi T, Sunaga N, Kudoh S, Chikamori K, Harada M, Tanaka H, Saito H, Saka H, Takeda K, Nogami N, Masuda N, Harada T, Kitagawa H, Horio H, Yamanaka T, Fukuoka M, Yamamoto N, Nakagawa K. A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer. Ann Oncol. 2017 Feb 1;28(2):285-291.
  7. Kato T, Honda Y, Kurita Y, Iwasaki A, Sato T, Kessoku T, Uchiyama S, Ogawa Y, Ohkubo H, Higurashi T, Yamanaka T, Usuda H, Wada K, Nakajima A. Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers. PLoS One. 2017 Apr 14;12(4):e0175626.
  8. Takahashi T, Yamanaka T, Seto T, Harada H, Nokihara H, Saka H, Nishio M, Kaneda H, Takayama K, Ishimoto O, Takeda K, Yoshioka H, Tachihara M, Sakai H, Goto K, Yamamoto N. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2017 May;18(5):663-671. 
  9. Yoshino T, Uetake H, Tsuchihara K, Shitara K, Yamazaki K, Oki E, Sato T, Naitoh T, Komatsu Y, Kato T, Yamanaka K, Iwasaki K, Soeda J, Hihara M, Yamanaka T, Ochiai A, Muro K. Rationale for and Design of the PARADIGM Study: Randomized Phase III Study of mFOLFOX6 Plus Bevacizumab or Panitumumab in Chemotherapy-naïve Patients With RAS (KRAS/NRAS) Wild-type, Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2017 Jun;16(2):158-163.
  10. Maehara Y, Shirabe K, Kohnoe S, Emi Y, Oki E, Kakeji Y, Baba H, Ikeda M, Kobayashi M, Takayama T, Natsugoe S, Haraguchi M, Yoshida K, Terashima M, Sasako M, Yamaue H, Kokudo N, Uesaka K, Uemoto S, Kosuge T, Sawa Y, Shimada M, Doki Y, Yamamoto M, Taketomi A, Takeuchi M, Akazawa K, Yamanaka T, Shimokawa M. Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial. Surg Today. 2017 Sep;47(9):1060-1071.
  11. Kunisaki C, Tanaka Y, Kosaka T, Miyamoto H, Sato S, Suematsu H, Yukawa N, Sato K, Izumisawa Y, Akiyama H, Taguri M, Yamanaka T, Endo I. A Comparative Study of Intravenous Injection Form and Oral Jelly Form of Alendronate Sodium Hydrate for Bone Mineral Disorder after Gastrectomy. Digestion. 2017;95(2):162-171.
  12. Chikamoto A, Inoue R, Komohara Y, Sakamaki K, Hashimoto D, Shiraishi S, Takamori H, Yamashita YI, Yoshida N, Yamanaka T, Yamashita Y, Baba H. Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer. Ann Surg Oncol. 2017 Jul;24(7):2040-2046.
  13. Wataya-Kaneda M, Nakamura A, Tanaka M, Hayashi M, Matsumoto S, Yamamoto K, Katayama I. Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex : A Randomized Clinical Trial. JAMA Dermatol. 2017 Jan 1;153(1):39-48. 
  14. Ishikawa H, Hara M, Ryuge M, Takafuji J, Youmoto M, Akira M, Nagasaka Y, Kabata D, Yamamoto K, Shintani A. Efficacy and safety of super selective bronchial artery coil embolisation for haemoptysis: a single-centre retrospective observational study. BMJ Open. 2017 Feb 17;7(2):e014805.   
  15. Arisawa A, Watanabe Y, Tanaka H, Takahashi H, Matsuo C, Fujiwara T, Fujimoto Y, Yamamoto K, Tomiyama N. Vessel-Masked Perfusion Magnetic Resonance Imaging With Histogram Analysis Improves Diagnostic Accuracy for the Grading of Glioma. J
    Comput Assist Tomogr. 2017 Nov/Dec;41(6):910-915.    
  16. Yoshida S, Fukushima S, Miyagawa S, Nakamura T, Yoshikawa Y, Hata H, Saito S, Yoshioka D, Domae K, Kashiyama N, Yamamoto K, Shintani A, Nakatani S, Toda K, Sawa Y. Mitral Valve Structure in Addition to Myocardial Viability Determines the Outcome of Functional Mitral Regurgitation After Coronary Artery Bypass Grafting. Circ J. 2017 Oct 25;81(11):1620-1627.   
  17. Takeuchi D, Kerdsin A, Akeda Y, Chiranairadul P, Loetthong P, Tanburawong N, Areeratana P, Puangmali P, Khamisara K, Pinyo W, Anukul R, Samerchea S, Lekhalula P, Nakayama T, Yamamoto K, Hirose M, Hamada S, Dejsirilert S, Oishi K. Impact of a Food Safety Campaign on Streptococcus suis Infection in Humans in Thailand. Am J Trop Med Hyg. 2017 Jun;96(6):1370-1377.  
  18. Nakamura A, Iwami D, Miyoshi H, Morita K, Taguri M, Terauchi Y, Shinohara N, Atsumi T. Impact of renal transplantation on glucose tolerance in Japanese recipients with impaired glucose tolerance. Diabet Med. 2017 Apr;34(4):569-576.
  19. Endo H, Kato T, Sakai E, Taniguchi L, Arimoto J, Kawamura H, Higurashi T, Ohkubo H, Nonaka T, Taguri M, Inamori M, Yamanaka T, Sakaguchi T, Hata Y, Nagase H, Nakajima A. Is a fecal occult blood test a useful tool for judging whether to perform capsule endoscopy in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy? Journal of Gastroenterology 2017 Feb; 52(2): 194– 202.
  20. Tanaka T, Taguri M, Fumita S, Okamoto K, Matsuo Y, Hayashi H. Retrospective study of unplanned hospital admission for metastatic cancer patients visiting the emergency department. Support Care Cancer 2017 May; 25(5): 1409–1415.
  21. Suwa Y, Matsuyama R, Goto K, Kadokura T, Sato M, Mori R, Kumamoto T, Taguri M, Miyasho T, Endo I. IL-7 and procalcitonin are useful biomarkers in the comprehensive evaluation of the severity of acute cholangitis. Journal of Hepato-Biliary-Pancreatic Sciences 2017 Feb; 24(2): 81–88.
  22. Ishibe A, Ota M, Fujii S, Suwa Y, Suzuki S, Suwa H, Momiyama M, Watanabe J, Watanabe K, Taguri M, Kunisaki C, Endo I. Midterm follow-up of a randomized trial of open surgery versus laparoscopic surgery in elderly patients with colorectal cancer. Surgical Endoscopy 2017 Oct; 31(10):3890-3897.
  23. Tada N, Haga Y, Suzuki S, Enta Y, Miyasaka M, Inoue H, Taguri M, Ishii K, Hata M, Sakuma M, Toyoda S, Inoue T, Ootomo T. Computed Tomography Score of Aortic Valve Tissue May Predict Cerebral Embolism During Transcatheter Aortic Valve Implantation. JACC: Cardiovascular Imaging 2017 Aug; 10(8): 960–962.
  24. Kato S, Saito N, Nakachi T, Fukui K, Iwasawa T, Taguri M, Kosuge M, Kimura K. Stress Perfusion Coronary Flow Reserve Versus Cardiac Magnetic Resonance for Known or Suspected CAD. Journal of the American College of Cardiology 2017 Aug; 70(7): 869–879.
  25. Umemura M, Kim JH, Aoyama H, Hoshino Y, Fukumura H, Nakakaji R, Sato I, Ohtake M, Akimoto T, Narikawa M, Tanaka R, Fujita T, Yokoyama U, Taguri M, Okumura S, Sato M, Eguchi H, Ishikawa Y. The iron chelating agent, deferoxamine detoxifies Fe(Salen)-induced cytotoxicity. Journal of Pharmacological Sciences 2017 Aug; 134(4): 203–210.
  26. Aoki K, Nagakura M, Taguri M, Kamiyama H, Masumura M, Furuie T, Oka M, Kamiko K, Nakajima S, Akema N, Terauchi Y. Effect of Switching From an Anti-Diabetic Loose Dose Combination to a Fixed Dose Combination Regimen at Equivalent Dosage for 6 Months on Glycemic Control in Japanese Patients With Type 2 Diabetes: A Pilot Study. Journal of Clinical Medicine Research Aug 2017; 9(8): 719–724.
  27. Tanaka H, Kanda M, Morita S, Taguri M, Nishikawa K, Shimada M, Muguruma K, Koeda K, Takahashi M, Nakamori M, Konno H, Tsuji A, Hosoya Y, Shirasaka T, Yamamitsu S, Sowa M, Kitajima M, Okajima M, Kobayashi M, Sakamoto J, Saji S, Hirakawa K. Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003). International Journal of Clinical Oncology Dec 2017; 22(6):1052-1059.
  28. Motoki Y, Miyagi E, Taguri M, Asai-Sato M, Enomoto T, Wark JD, Garland SM. Comparison of Different Recruitment Methods for Sexual and Reproductive Health Research: Social Media-Based Versus Conventional Methods. Journal of Medical Internet Research Mar 2017; 19(3): e73.
  29. Shimizu F, Muto S, Taguri M, Ieda T, Tsujimura A, Sakamoto Y, Fujita K, Okegawa T, Yamaguchi R, Horie S. Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis. International Journal of Urology May 2017; 24(5): 367–372.
  30. Miyauchi M, Kishida I, Suda A, Shiraishi Y, Fujibayashi M, Taguri M, Ishii C, Ishii N, Moritani T, Hirayasu Y. Long term effects of smoking cessation in hospitalized schizophrenia patients. BMC Psychiatry Mar 2017; 17(1): 87.
  31. Takahashi K, Nakamura A, Miyoshi H, Nomoto H, Kameda H, Cho KY, Nagai S, Shimizu C, Taguri M, Terauchi Y, Atsumi T. Factors associated with an inadequate hypoglycemia in the insulin tolerance test in Japanese patients with suspected or proven hypopituitarism. Endocrine Journal Apr 2017; 64(4): 387–392.
  32. Hattori S, Suda A, Kishida I, Miyauchi M, Shiraishi Y, Fujibayashi M, Tsujita N, Ishii C, Ishii N, Moritani T, Taguri M, Hirayasu Y. Associations of ABCB1 gene polymorphisms with aripiprazole-induced autonomic nervous system dysfunction in schizophrenia. Schizophrenia Research Nov 2017, in press.
  33. Ishii T, Taguri M, Tamura K, Oyama K. Evaluation of the effectiveness of xanthine oxidoreductase inhibitors on haemodialysis patients using a marginal structural model. Scientific Reports Oct 2017; 7(1): 14004.
  34. Kato S, Saito N, Nakachi T, Fukui K, Iwasawa T, Taguri M, Kosuge M, Kimura K, Tamura K. Reply: Importance of Resting Coronary Blood Flow as the Main Determinant of Coronary Flow Reserve. Journal of the American College of Cardiology. Dec 2017; 70(22): 2839-2840.
  35. Fujita Y, Iwasaki A, Sato T, Fujisawa T, Sekino Y, Hosono K, Matsuhashi N, Sakamaki K, Nakajima A, Kubota K. Feasibility of Endoscopic Papillary Large Balloon Dilation in Patients with Difficult Bile Duct Stones without Dilatation of the Lower Part of the Extrahepatic Bile Duct. Gut Liver. 2017 Jan 15;11(1):149-155.

2016年

  1. Shitara K, Yonesaka K, Denda T, Yamazaki K, Moriwaki T, Tsuda M, Takano T, Okuda H, Nishina T, Sakai K, Nishio K, Tokunaga S, Yamanaka T, Boku N, Hyodo I, Muro K. Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer-WJOG 6210G. Cancer Sci. 2016 Dec;107(12):1843-1850
  2. Tanaka F, Hasegawa S, Kondo N, Miyahara R, Date H, Atagi S, Kawahara M, Yamanaka T, Manabe T, Wada H. A Multicenter Feasibility Study of EBUS-TBNA for Potentially Operable Non-Small Cell Lung Cancer: The JMTO LC07-02 Study (UMIN000001280). Oncol Res Treat. 2016;39(10):629-633.
  3. Goto S, Hasegawa S, Hata H, Yamaguchi T, Hida K, Nishitai R, Yamanokuchi S, Nomura A, Yamanaka T, Sakai Y. Differences in surgical site infection between laparoscopic colon and rectal surgeries: sub-analysis of a multicenter randomized controlled trial (Japan-Multinational Trial Organization PREV 07-01). Int J Colorectal Dis. 2016 Nov;31(11):1775-1784.
  4. Miyauchi M, Kishida I, Suda A, Shiraishi Y, Hattori S, Fujibayashi M, Taguri M, Ishii C, Ishii N, Moritani T, Hirayasu Y. Association of the Cholinergic Muscarinic M2 Receptor with Autonomic Nervous System Activity in Patients with Schizophrenia on High-Dose Antipsychotics. Neuropsychobiology. 2016;74(1):60-67.
  5. Ieda T, Muto S, Shimizu F, Taguri M, Yanada S, Kitamura K, Terai K, Saito K, Ogishima T, Nagata M, Ide H, Okegawa T, Wakumoto Y, Sakamoto Y, Tsujimura A, Yamaguchi R, Nutahara K, Horie S. Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia. EBioMedicine. 2016 Oct; 12:98-104.
  6. Kamiko K, Aoki K, Kamiyama H, Taguri M, Terauchi Y. Comparison of Plasma Glucose and Gut Hormone Levels Between Drinking Enteral Formula Over a Period of 5 and 20 Minutes in Japanese Patients With Type 2 Diabetes: A Pilot Study. J Clin Med Res. 2016 Oct;8(10):749-52.  
  7. Oshiro H, Czerniak BA, Sakamaki K, Tsuta K, Bondaruk J, Keyhani A, Dinney CP, Nagai T, Kamat AM. Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study. Medicine (Baltimore). 2016 Aug;95(31): e4500.  
  8. Murakami N, Kato S, Nakano T, Uno T, Yamanaka T, Sakurai H, Yoshimura R, Hiratsuka J, Kuroda Y, Yoshio K, Itami J. A phase I/II clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced cervical cancer. BMC Cancer. 2016 Aug 6:640.
  9. Kiyokuni M, Konishi M, Sakamaki K, Kawashima C, Narikawa M, Doi H, Iwata K, Tomari S, Nakayama N, Komura N, Mitsuhashi T, Yano H, Sugano T, Ishigami T, Endo T, Ishikawa T, Yamanaka T, Kimura K. Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction. Int J Cardiol. 2016 221:321-326.
  10. Suzuki K, Yamanaka T, Hashimoto H, Shimada Y, Arata K, Matsui R, Goto K, Takiguchi T, Ohyanagi F, Kogure Y, Nogami N, Nakao M, Takeda K, Azuma K, Nagase S, Hayashi T, Fujiwara K, Shimada T, Seki N, Yamamoto N. Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study. Ann Oncol. 2016 Aug 1601-6.
  11. Yamanaka T, Oki E, Yamazaki K, Yamaguchi K, Muro K, Uetake H, Sato T, Nishina T, Ikeda M, Kato T, Kanazawa A, Kusumoto T, Chao C, Lopatin M, Krishnakumar J, Bailey H, Akagi K, Ochiai A, Ohtsu A, Ohashi Y, Yoshino T. 12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study. J Clin Oncol. 2016 Aug 34(24):2906-13
  12. Kawahara T, Furuya K, Nakamura M, Sakamaki K, Osaka K, Ito H, Ito Y, Izumi K, Ohtake S, Miyoshi Y, Makiyama K, Nakaigawa N, Yamanaka T, Miyamoto H, Yao M, Uemura H. Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy. BMC Cancer. 2016 Mar 16:185.
  13. Takeda M, Yamanaka T, Seto T, Hayashi H, Azuma K, Okada M, Sugawara S, Daga H, Hirashima T, Yonesaka K, Urata Y, Murakami H, Saito H, Kubo A, Sawa T, Miyahara E, Nogami N, Nakagawa K, Nakanishi Y, Okamoto I. Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial. Cancer. 2016 Apr 122(7):1050-9.
  14. Hata H, Yamaguchi T, Hasegawa S, Nomura A, Hida K, Nishitai R, Yamanokuchi S, Yamanaka T, Sakai Y. Oral and Parenteral Versus Parenteral Antibiotic Prophylaxis in Elective Laparoscopic Colorectal Surgery (JMTO PREV 07-01): A Phase 3, Multicenter, Open-label, Randomized Trial. Ann Surg. 2016 Jun 263(6):1085-91.
  15. Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y, Ono M, Eguchi Y, Inoue T,Yamanaka T, Wada K, Saito S, Nakajima A. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. Gastroenterology. 2016 Mar 150(3):626-637.e7.
  16. Hasegawa S, Okada M, Tanaka F, Yamanaka T, Soejima T, Kamikonya N, Tsujimura T, Fukuoka K, Yokoi K, Nakano T. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial). Int J Clin Oncol. 2016 Jun 21(3):523-30.
  17. Nishiuchi H, Taguri M, Ishikawa Y. Using a Marginal Structural Model to Design a Theory-Based Mass Media Campaign. PLoS One. 2016 Jul 11(7):e0158328.
  18. Kamiyama H, Aoki K, Nakajima S, Shinoda K, Kamiko K, Taguri M, Terauchi Y. Effect of Switching from Sulphonylurea to Repaglinide Twice or Three Times Daily for 4 Months on Glycemic Control in Japanese Patients with Type 2 Diabetes.InternMed.2016;55(13):1697-703.
  19. Kikuchi Y, Hiroshima Y, Matsuo K, Kawaguchi D, Murakami T, Yabushita Y, Endo I, Taguri M, Koda K, Tanaka K. A Randomized Clinical Trial of Preoperative Administration of Branched-Chain Amino Acids to Prevent Postoperative Ascites in Patients with Liver Resection for Hepatocellular Carcinoma. Ann Surg Oncol. 2016 Jun 23.
  20. Tsuburaya A, Sugimoto N, Imamura H, Nishikawa K, Imamoto H, Tsujinaka T, Esaki T, Horita Y, Kimura Y, Fujiya T, Takayama O, Oono R, Yabusaki H, Taguri M, Morita S, Yamada Y, Tan P, Ninomiya M, Furukawa H, Sasako M. Molecular Biomarker Study in a Randomised Phase III Trial of Irinotecan Plus S-1 versus S-1 for Advanced Gastric Cancer (GC0301/TOP-002).Clin Oncol (R Coll Radiol). 2016 Aug;28(8):e45-51.
  21. Aoki K, Tajima K, Taguri M, Terauchi Y. Effect of dehydroepiandrosterone (DHEA) on Akt and protein kinase C zeta (PKCζ) phosphorylation in different tissues of C57BL6, insulin receptor substrate (IRS)1(-/-), and IRS2(-/-) male mice fed a high-fat diet. J Steroid Biochem Mol Biol. 2016 May;159:110-20.
  22. Uchiyama Y, Nakashima M, Watanabe S, Miyajima M, Taguri M, Miyatake S, Miyake N, Saitsu H, Mishima H, Kinoshita A, Arai H, Yoshiura K, Matsumoto N. Ultra-sensitive droplet digital PCR for detecting a low-prevalence somatic GNAQ mutation in Sturge-Weber syndrome. Sci Rep. 2016 Mar ;6:22985.
  23. Higurashi T, Hosono K, Takahashi H, Komiya Y, Umezawa S, Sakai E, Uchiyama T, Taniguchi L, Hata Y, Uchiyama S, Hattori A, Nagase H, Kessoku T, Arimoto J, Matsuhashi N, Inayama Y, Yamanaka S,Taguri M, Nakajima A. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial. Lancet Oncol.2016Apr;17(4):475-83.
  24. Shibata E, Aoki K, Tajima K, Taguri M, Terauchi Y. Comparison of efficacy and safety of taking miglitol dissolved in water during a meal and taking a miglitol tablet just before a meal in patients with type 2 diabetes. Expert Opin Pharmacother. 2016;17(7):889-94.
  25. Yokota T, Tachibana H, Konishi T, Yurikusa T, Hamauchi S, Sakai K, Nishikawa M, Suzuki M, Naganawa Y, Hagihara T, Tsumaki H, Kubo T, Sato M, Taguri M, Morita S, Eguchi T, Kubota K, Zenda S. Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy. Support Care Cancer. 2016 Jul;24(7):3029-36.
  26. Sakai R, Taguri M, Oshima K, Mori T, Ago H, Adachi S, Morita S, Taniguchi S, Fukuda T, Ohashi K, Eto T, Miyamura K, Iwato K, Kobayashi N, Kanamori H, Morishima Y, Nagamura-Inoue T, Sakamaki H, Atsuta Y, Murata M. A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey. Int J Hematol. 2016 Mar;103(3):322-33.
  27. Shimizu M, Mitsudo K, Koike I, Taguri M, Iwai T, Koizumi T, Oguri S, Kioi M, Hirota M, Inoue T, Tohnai I. Prognostic value of 2-[(18) F]fluoro-2-deoxy-D-glucose positron emission tomography for patients with oral squamous cell carcinoma treated with retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Mar;121(3):239-47.
  28. Nagakura J, Yamakawa T, Taguri M, Tsuchiya H, Shigematsu E, Suzuki J, Morita S, Kadonosono K, Terauchi Y. Effects of exenatide and liraglutide on 24-hour glucose fluctuations in type 2 diabetes. Endocr J. 2016;63(3):239-47.
  29. Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y, Ono M, Eguchi Y, Inoue T, Yamanaka T, Wada K, Saito S, Nakajima A. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. Gastroenterology. 2016 Mar;150(3):626-637.e7.
  30. Miyoshi Y, Uemura H, Umemoto S, Sakamaki K, Taguri M, Suzuki K, Shibata Y, Masumori N, Ichikawa T, Mizokami A, Sugimura Y, Nonomura N, Sakai H, Honma S, Harada M, Kubota Y. Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer. Prostate. 2016 Mar;76(4):376-82.
  31. Mizushima T, Asai-Sato M, Akimoto K, Nagashima Y, Taguri M, Sasaki K, Nakaya MA, Asano R, Tokinaga A, Kiyono T, Hirahara F, Ohno S, Miyagi E. Aberrant Expression of the Cell Polarity Regulator aPKCλ/ι is Associated With Disease Progression in Cervical Intraepithelial Neoplasia (CIN): A Possible Marker for Predicting CIN Prognosis. Int J Gynecol Pathol. 2016 Mar;35(2):106-17
  32. Kato S, Saito N, Kirigaya H, Gyotoku D, Iinuma N, Kusakawa Y, Iguchi K, Nakachi T, Fukui K, Futaki M, Iwasawa T, Taguri M, Kimura K, Umemura S. Incremental prognostic value of the SYNTAX score to late gadolinium-enhanced magnetic resonance images for patients with stable coronary artery disease. Heart Vessels. 2016 Jun;31(6):871-80.
  33. Yamada T, Yoshikawa T, Taguri M, Hayashi T, Aoyama T, Sue-Ling HM, Bonam K, Hayden JD, Grabsch HI. The survival difference between gastric cancer patients from the UK and Japan remains after weighted propensity score analysis considering all background factors. Gastric Cancer. 2016 Apr;19(2):479-89.
  34. Sakamaki K, Kamiura T, Morita Y, Iba K, Yoshida S, Wakana A, Tsuchiya S, Fukimbara S, Suganami H. Current Practice on Multiplicity Adjustment and Sample Size Calculation in Multi-arm Clinical Trials: An Industry Survey in Japan. Therapeutic Innovation & Regulatory Science 2016 Nov;50(6):846-852.
  35. Inoue M, Yamane S, Sato S, Sakamaki K, Arakawa A, Kadonosono K. Comparison of time to retreatment and visual function between ranibizumab and aflibercept in age-related macular degeneration. American Journal of Ophthalmology 2016 Sep;169:95-103..
  36. Ishikawa T, Sakamaki K, Narui K, Kaise H, Tsugawa K, Ichikawa Y, Mukai H. Prospective cohort study of febrile neutropenia in breast cancer patients with neoadjuvant and adjuvant chemotherapy: CSPOR-BC FN study. Japanese Journal of Clinical Oncology 2016; 46(7):692-5. 
  37. Taira N, Fujisawa T, Araki K, Iwamoto T, Sakamaki K, Takahashi M, Aihara T, Mukai H. Cohort study of secondary endocrine therapy in metastatic breast cancer with a poor response to initial endocrine therapy. Journal of Clinical Trials 2016; 6: 1000260.
  38. Kobayashi S, Inoue M, Yamane S, Sakamaki K, Arakawa A, Kadonosono K. Long-term outcomes after preoperative intravitreal injection of bevacizumab before trabeculectomy for neovascular glaucoma. Journal of Glaucoma 2016; 25(3): 281-284.
  39. Miyoshi Y, Uemura H, Umemoto S, Sakamaki K, Taguri M, Suzuki K, Shibata Y, Masumori N, Ichikawa T, Mizokami A, Sugimura Y, Nonomura N, Sakai H, Honma S, Harada M Kubota Y. Low serum dehydroepiandrosterone examined by liquid chromatography‐tandem mass spectrometry correlates with poor prognosis in hormone‐naïve prostate cancer. The Prostate 2016; 76(4): 376-382.
  40. Kawahara T, Furuya K, Nakamura M, Sakamaki K, Osaka K, Ito H, Ito Y, Izumi K, Ohtake S, Miyoshi Y, Makiyama K, Nakaigawa N, Yamanaka T, Miyamoto H, Yao M, Uemura H. Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy. BMC Cancer 2016; 16(1): 1.
  41. Numata K, Oshima T, Sakamaki K, Yoshihara K, Aoyama T, Hayashi T, Yamada T, Sato T, Cho H, Shiozawa M, Yoshikawa T, Rino Y, Kunisaki C, Akaike M, Imada M, Masuda M. Clinical significance of IGF1R gene expression in patients with stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1. Journal of Cancer Research and Clinical Oncology 2016; 142(2): 415-422.
  42. Kozuki T, Nogami N, Kitajima H, Iwasawa S, Sakaida E, Takiguchi Y, Ikeda S, Yoshida M, Kato T, Miyamoto S, Sakamaki K, Shinkai T, Watanabe K. Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015. BMC Cancer 2016; 16(1): 1.
  43. Watanabe K, Tsuboi M, Sakamaki K, Nishii T, Yamamoto T, Nagashima T , Ando K, Ishikawa Y, Woo T, Adachi H, Kumakiri Y, Maehara T, Nakayama H, Kumakiri Y. Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery 2016; 49(6): 1624-1631.
  44. Ogino I, Watanabe S, Iwahashi N, Kosuge M, Sakamaki K, Kunisaki C, Kimura K. Symptomatic radiation-induced cardiac disease in long-term survivors of esophageal cancer. Strahlentherapie und Onkologie 2016; 192(6): 359-367.
  45. Enomoto K, Aoki S, Toma R, Fujiwara K, Sakamaki K, Hirahara F. Pregnancy Outcomes Based on Pre-Pregnancy Body Mass Index in Japanese Women. PLoS One 2016; 11(6): e0157081.
  46. Hirata G, Aoki S, Sakamaki K, Takahashi T, Hirahara F, Ishikawa H. Clinical characteristics of mirror syndrome: a comparison of 10 cases of mirror syndrome with non-mirror syndrome fetal hydrops cases. The Journal of Maternal-Fetal & Neonatal Medicine 2016; 29(16): 2630-2634.
  47. Miyoshi Y, Uemura H, Umemoto S, Sakamaki K, Taguri M, Suzuki K, Shibata Y, Masumori N, Ichikawa T, Mizokami A, Sugimura Y, Nonomura N, Sakai H, Honma S, Harada M, Sugimura Y. Low serum dehydroepiandrosterone examined by liquid chromatography‐tandem mass spectrometry correlates with poor prognosis in hormone‐naïve prostate cancer. The Prostate 2016; 76(6): 376-382.
  48. Tanisho Y, Shigemura J, Kubota K, Tanigawa T, Bromet EJ, Takahashi S, Matsuoka Y, Nishi D, Nagamine M, Harada N, Tanichi M, Takahashi Y, Shimizu K, Nomura S, Yoshino A; Fukushima NEWS Project Collaborators. The longitudinal mental health impact of Fukushima nuclear disaster exposures and public criticism among power plant workers: the Fukushima NEWS Project study. Psychol Med. 2016 Aug 1-9.